Biomea Fusion (BMEA) Liabilities and Shareholders Equity (2020 - 2026)
Biomea Fusion's (BMEA) quarterly Liabilities and Shareholders Equity came in at $36.9 million in Q2 2026, down 49.6% year-over-year from $73.2 million in Q2 2025, and down 20.51% quarter-over-quarter from $46.4 million in Q1 2026.
Powered by 
Analysis
Biomea Fusion (BMEA) Liabilities and Shareholders Equity (2020 - 2026) Analysis & Trends
Biomea Fusion has disclosed Liabilities and Shareholders Equity across 7 years of filings, most recently posting $36.9 million for Q2 2026.
- In Q2 2026, Liabilities and Shareholders Equity fell 49.6% year-over-year to $36.9 million; the TTM figure through Jun 2026 stood at $197.0 million (down 38.16% YoY), while the FY2025 annual figure was $58.6 million, down 26.73% from the prior year.
- Liabilities and Shareholders Equity came in at $36.9 million for Q2 2026 at Biomea Fusion, down from $46.4 million in the prior quarter.
- In the past five years, Liabilities and Shareholders Equity ranged from a high of $248.7 million in Q2 2023 to a low of $36.9 million in Q2 2026.
- Average Liabilities and Shareholders Equity over 5 years is $123.2 million, with a median of $121.0 million recorded in 2022.
- Year-over-year, Liabilities and Shareholders Equity soared 192.05% in 2022 and slumped 67.33% in 2025.
- Over 5 years, Liabilities and Shareholders Equity stood at $129.3 million in 2022, then surged by 54.61% to $199.9 million in 2023, then slumped by 60.02% to $79.9 million in 2024, then slipped by 26.73% to $58.6 million in 2025, then slumped by 37.05% to $36.9 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $36.9 million in Q2 2026, $46.4 million in Q1 2026, and $58.6 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 650.65 Bn | 629.89 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 466.34 Bn | 459.82 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 362.11 Bn | 355.02 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 267.81 Bn | 260.52 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Pfizer | 157.31 Bn | 145.91 Bn | 10.94 Bn | 201.13 Bn |
| 6 | Bristol Myers Squibb | 128.75 Bn | 117.69 Bn | 9.25 Bn | 87.63 Bn |
| 7 | Sanofi | 51.80 Bn | 44.84 Bn | 10.79 Bn | 150.01 Bn |
| 8 | Revolution Medicines | 40.91 Bn | 40.91 Bn | - | 4.32 Bn |
| 9 | BeOne Medicines | 39.65 Bn | 34.55 Bn | 1.53 Bn | 9.18 Bn |
| 10 | Biomea Fusion | 132.65 Mn | 132.65 Mn | - | 36.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 36.87 Mn |
| Mar 31, 2026 | 46.39 Mn |
| Dec 31, 2025 | 58.57 Mn |
| Sep 30, 2025 | 55.19 Mn |
| Jun 30, 2025 | 73.16 Mn |
| Mar 31, 2025 | 55.06 Mn |
| Dec 31, 2024 | 79.94 Mn |
| Sep 30, 2024 | 110.42 Mn |
| Jun 30, 2024 | 136.16 Mn |
| Mar 31, 2024 | 168.49 Mn |
| Dec 31, 2023 | 199.93 Mn |
| Sep 30, 2023 | 225.09 Mn |
| Jun 30, 2023 | 248.67 Mn |
| Mar 31, 2023 | 112.64 Mn |
| Dec 31, 2022 | 129.31 Mn |
| Sep 30, 2022 | 145.05 Mn |
| Jun 30, 2022 | 161.74 Mn |
| Mar 31, 2022 | 174.86 Mn |
| Dec 31, 2021 | 185.71 Mn |
| Sep 30, 2021 | 199.40 Mn |
API Access
Biomea Fusion Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BMEA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "BMEA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=BMEA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();